X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

ACHEMA 2022 addresses the industry’s key issues digitalisation and sustainability

Content Team by Content Team
14th June 2022
in Manufacturing, Middle East and South Asia, Press Statements
ACHEMA 2022 addresses the industry's key issues digitalisation and sustainability

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

In addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalisation, the current global political situation also poses massive challenges for the process industry. Which technologies can be used to achieve defossilisation? How to secure and enhance regional and global supply chain networks? And what hurdles must be overcome in the digitalisation of the industry? ACHEMA 2022 offers answers and solutions to these and many more questions.

Europe aims to become climate-neutral by 2050. In line with this target, the chemical industry is working on technologies to achieve this goal. What are the opportunities, challenges, and obstructions? How do we shape the necessary political framework and incentives? Which financial instruments are required? These questions will be addressed at the opening event of ACHEMA entitled “Climate-Neutral Chemical Industry” on 22 August 2022 from 5 pm at the end of the first exhibition day.

After the welcome address and opening of ACHEMA by Klaus Schäfer, Chief Technology Officer of Covestro AG and Chairman of DECHEMA e.V., Martin Brudermüller, President of CEFIC – The European Chemical Industry Council and CEO of BASF SE, will present the perspective of the European chemical industry in his keynote speech. Open questions will be discussed in the subsequent panel discussion, with Martijn Smit, Business Development Director of Northern Lights, and Ernst Rauch, Chief Climate and Geo Scientist of Munich Re, joining the panel.

Green Innovation Zone shows solutions for a more sustainable future

The challenges and solutions for a more sustainable future are also addressed by the “Green Innovation Zone”: This special area brings together pioneers, experts and solution providers from industry, politics, and science with decisionmakers and users. The Green Innovation Zone highlights green innovations and the challenges faced by the process industry on its way to climate-neutral production. Five areas in particular will be in the spotlight at ACHEMA:  climate-neutral production, circular economy, industrial water, sustainable chemistry, bio-based economy.

“The process industry will have to electrify its facilities across the board and use hydrogen as an energy source in the medium term if it wants to live up to its responsibility for sustainable value creation,” adds Frank Jenner, Global Chemicals & Advanced Materials Industry Leader at EY, the main green innovation partner of ACHEMA 2022. “The industry is already going to great lengths and it’s a huge challenge, but it can be done.”

„With this year’s ACHEMA – perhaps more than ever – we are sending out a signal that technological cooperation across industry boundaries, but also across national borders, is indispensable for solving the significant crises of our time“, says Thomas Scheuring, CEO of DECHEMA Ausstellungs-GmbH. Björn Mathes, Member of the Board of DECHEMA Ausstellungs-GmbH, adds: „As an industry platform, we can create a nucleus in our lecture formats and in the discussions at the stands, in which the industry works together on a solution.”

Digital Hub and Digital Lab offer digitalisation at your fingertips

The topic of digitalization has finally claimed a top spot on the agenda of the process industry. The new exhibition group “Digital Hub” contributes to this: It is the central meeting point for digital experts and all participants interested in or actively involved in the digital transformation of the process industry. The exhibition area with a central stage puts digital showcases of the process industry in the spotlight and offers the latest insights from experts and solution providers and facilitates future-oriented discussions.

A total of six use cases for the connected and digitalized laboratory will be presented at the Digital Lab Action Area – the smart lab of tomorrow to experience, touch and try out. Equipment and software manufacturers will demonstrate cross-manufacturer digitalization solutions using relevant practical examples. The spectrum ranges from Cobot-assisted work processes for sample preparation and analysis, user-oriented process control with Laboratory Execution Systems, to horizontally and vertically connected yet modularly adaptable equipment solutions with the perspective of shared laboratory infrastructure and seamless integration between sample input and quality-assured analysis results. Innovative software and device solutions are supported by the Laboratory & Analytical Device Standard (LADS) for OPC UA.

„Digitalisation, sustainability, security of supply – the challenges ahead are enormous and can only be overcome together and across sectors”, says Thomas Scheuring. “Let us therefore use ACHEMA in August 2022 as the world’s only comprehensive showcase of the latest technology trends in our industry to find and tackle solutions together.”

Previous Post

GSK Unveils Its Transformation Through New Branding And Logo

Next Post

GARDP Helps Bugworks Assess New Antibiotics Effectiveness

Related Posts

FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Insights

Green Chemistry in Sustainable API Manufacturing

26th September 2025
active pharmaceutical ingredients supply chain
Drug Development

Future of Active Pharmaceutical Ingredients Supply

26th September 2025
pharmaceutical excipients for new therapies
Drug Development

Advances in Pharmaceutical Excipients for New Therapies

26th September 2025
Next Post

GARDP Helps Bugworks Assess New Antibiotics Effectiveness

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In